Secondary Data. In its evaluation activities, CMS may use data or information submitted by the ACO as well as claims submitted to CMS for items and services furnished to Next Generation Beneficiaries. This data may include, but is not limited to:
Secondary Data a) Secondary data that directly affect the potential distribution of a pest or disease can be used to determine the potential area of infestation. Secondary data will only be used if all parties on the NBMCC agree and only if it is available, highly relevant and incontrovertible.
Secondary Data. In its evaluation activities, CMS or its designee(s) may use data or information submitted by the Hospital for quality and monitoring purposes as well as claims submitted by practitioners, providers and suppliers to CMS for items and services furnished to Maryland Medicare Beneficiaries. These data may include, but are not limited to:
Secondary Data. The Parkview Health CHNA Dashboard1, developed by Healthy Communities Institute, was used to access secondary data. Additional state and national secondary data sources were accessed for more recent and geographically-specific information, including the following: • Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC-NCHHSTP) Atlas: A federal source of data regarding sexually transmitted infections and diseases.
Secondary Data a) Secondary data that directly affect the potential distribution of a disease can be used to determine the potential area of infection. Secondary data will only be used if all parties on the NBMCC agree and only if it is available, highly relevant and incontrovertible.
Secondary Data. In its evaluation activities, CMS or its designee(s) may use data or information submitted by or made available by the Participant as well as claims submitted to CMS for items and services furnished to beneficiaries. These data may include, but are not limited to:
Secondary Data. We reduced the initial eight documents to six documents, because a short initial review of the documents showed that the DESCA-A (B) and the DESCA-B (C) CAM are largely redundant. Hence, we decided not to include the uncommented version DESCA-B in our analysis in order to avoid negative redundancy. For the same reasons, we decided not to analyse the (D’) EUCAR-B CAM. Hence, we analysed the following six CAM’s (in alphabetical ordering):
Secondary Data. The type of secondary data used in this study is volatility data from all stocks with the largest number of assets listed on the Indonesia Stock Exchange for the 2016 – 2021 sample period.
Secondary Data. 4.1 Affiliated Projects agree to provide BASIS with any Secondary Data arising from their use of the Data, within a reasonable period of time and with sufficient information to enable informed, independent research use. The source of Secondary Data shall be acknowledged in all Publications, as appropriate.
Secondary Data. Secondary data i nclude existing information used as basis for future data collection activities. These data may include: Data from an organization o r facility other than the one current ly/ planning to collect new data. Background information from other data collectors or state, federal, or local agencies. Information obtained from the published literature . Other types of information such as photographs , topographical maps, or outputs from computer models. The facility -specific work plan shall include a discussion of the types of non -direct information source used, how the information was used, and the assumptions made that affect the use of the informat ion. The quality acceptance criteria for these data should also be discussed in terms of the current project quality objectives. Figure 3 -1 presents a generalized procedure for evaluation of secondary data .
